Your prediction
Pros and Cons of Braskem Pfd ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Braskem Pfd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Braskem Pfd ADR | 1.640% | 0.813% | 0.000% | -44.643% | -31.111% | -71.329% | -62.985% |
| Braskem Pfd A | -0.860% | -11.538% | -1.709% | -56.767% | -39.791% | -72.222% | -69.086% |
| Ingevity Corp | 3.080% | 13.264% | 19.509% | 14.072% | 33.065% | - | - |
| PTT Global Chemical -fgn- | -2.910% | -3.846% | -1.961% | -24.812% | -23.077% | -59.350% | -68.944% |
Comments
Braskem S.A. (NYSE: BAK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating.
Show more
Ratings data for BAK provided by MarketBeat